Helicobacter pylori: Primary Susceptibility to Clarithromycin in vitro in Nova Scotia
Resistance to antimicrobial agents is a major determinant of the efficacy of regimens to eradicate Helicobacter pylori. Clarithromycin (CLA) has become one of the most commonly used antibi...
Saved in:
| Main Authors: | Linda M Best, David JM Haldane, Gregory S Bezanson, Sander JO Veldhuyzen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1997-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1997/159637 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subcutaneous Dirofilariasis in Nova Scotia
by: David JM Haldane, et al.
Published: (1996-01-01) -
Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01) -
Is the Decreasing Resistance to Treat Helicobacter pylori the Result of Improved Efficacy?
by: Sander JO Veldhuyzen van Zanten
Published: (1994-01-01) -
Helicobacter Pylori Infection and Frequency of Clarithromycin Resistance by qPCR
by: Samia Perwaiz Khan, et al.
Published: (2022-10-01) -
Detection of Clarithromycin Resistance in Helicobacter pylori: Advancing Diagnostic Approaches
by: Yong Hwan Kwon
Published: (2025-03-01)